ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

SP

Shanghai Pulmonary Hospital at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Shanghai Pulmonary Hospital takes part in 6 sessions at ESMO 2026 in Madrid. Its program centres on lung cancer and treatment response. It examines how tumour cells change during targeted therapy and studies treatments before surgery for lung cancer.

OrganizationESMO 2026 Attendance
SP
Shanghai Pulmonary Hospital
Shanghai, China
Cancer centre & hospital
Specialist pulmonary hospital in Shanghai, China.
Poster
Fri Oct 23
13:00–15:00
Spatial mapping of acidic niches in lung cancer and nodal metastasis
ePoster session 22
Lung & thoracic cancers
Poster
Fri Oct 23
15:15–16:00
Poster
Sat Oct 24
12:00–12:45
Targeting the YAP1–PVR axis enhances TIGIT blockade with PD-L1–independent antitumor activity in NSCLC
Saturday Poster Display session 3
Lung & thoracic cancers
Poster
Mon Oct 26
12:00–12:45
Poster
Mon Oct 26
12:00–12:45
Neoadjuvant therapy in stage III large cell neuroendocrine carcinoma
Monday Poster Display session 4
Lung & thoracic cancers
Abstract
Mon Oct 26
14:55–15:05
4243O - Single-cell transcriptomic analysis of EGFR-mutant lung adenocarcinoma reveals dynamic tumor ecosystem subtypes during TKI treatment
Proffered paper 2: Basic science and translation research
Biomarkers & precision oncology

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Shanghai Pulmonary Hospital

Tell us what you sell and we’ll find the people at Shanghai Pulmonary Hospital most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction